Benralizumab: Resolution of Eosinophilic Pulmonary Vasculitis in a Patient With EGPA

被引：10

作者：

Bormioli, S. ^{[1
]}

Vultaggio, A. ^{[2
]}

Nencini, F. ^{[2
]}

Comin, CE. ^{[3
]}

Bercich, L. ^{[4
]}

Bezzi, M. ^{[5
]}

Vivarelli, E. ^{[2
]}

Calosi, L. ^{[6
,7
]}

Chiccoli, F. ^{[1
]}

Matucci, A. ^{[2
]}

机构：

[1] Univ Florence, Immunol & Cellular Therapy, AOU Careggi, Florence, Italy

[2] Univ Florence, Immunoallergol Unit, AOU Careggi, Florence, Italy

[3] Univ Florence, Dept Expt & Clin Med, Sect Surg Histopathol & Mol Pathol, Florence, Italy

[4] ASST Spedali Civili Brescia, Dept Pathol, Brescia, Italy

[5] ASST Spedali Civili Brescia, UOC Pneumol Endoscop Unit, Brescia, Italy

[6] Univ Florence, Dept Expt & Clin Med, Sect Anat & Histol, Florence, Italy

[7] Univ Florence, Res Unit Histol & Embryol, Florence, Italy

来源：

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2021年 / 31卷 / 06期

关键词：

Asthma; Eosinophilic vasculitis; Bronchial alveolar lavage; Benralizumab; EGPA; GRANULOMATOSIS; MEPOLIZUMAB;

D O I：

10.18176/jiaci.0689

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：519 / 521

页数：3

共 9 条

[1] Rapid onset of effect of benralizumab on respiratory symptoms in a patient with eosinophilic granulomatosis with polyangiitis
Coppola, Angelo
Flores, Krisstopher Richard
De Filippis, Francesca
[J]. RESPIRATORY MEDICINE CASE REPORTS, 2020, 30
[2] Mepolizumab for the Treatment of Eosinophilic Granulomatosis With Polyangiitis: Our Experience
Diaz-Campos, R. M.
Prudencio-Ribera, V. C.
Garcia-Moguel, I
Fernandez-Rodriguez, C.
Corral-Blanco, M.
Jarrin-Estupinan, M. E.
Melero-Moreno, C.
[J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (05) : 384 - 385
[3] Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy
Faverio, Paola
Bonaiti, Giulia
Bini, Francesco
Vaghi, Adriano
Pesci, Alberto
[J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 2385 - 2395
[4] Benralizumab: A New Approach for the Treatment of Severe Eosinophilic Asthma
Gonzalez I, Davila
Benitez F, Moreno
Quirce, S.
[J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (02) : 84 - 93
[5] 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Jennette, J. C.
Falk, R. J.
Bacon, P. A.
Basu, N.
Cid, M. C.
Ferrario, F.
Flores-Suarez, L. F.
Gross, W. L.
Guillevin, L.
Hagen, E. C.
Hoffman, G. S.
Jayne, D. R.
Kallenberg, C. G. M.
Lamprecht, P.
Langford, C. A.
Luqmani, R. A.
Mahr, A. D.
Matteson, E. L.
Merkel, P. A.
Ozen, S.
Pusey, C. D.
Rasmussen, N.
Rees, A. J.
Scott, D. G. I.
Specks, U.
Stone, J. H.
Takahashi, K.
Watts, R. A.
[J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (01): : 1 - 11
[6] Eosinophils in vasculitis: characteristics and roles in pathogenesis
Khoury, Paneez
Grayson, Peter C.
Klion, Amy D.
[J]. NATURE REVIEWS RHEUMATOLOGY, 2014, 10 (08) : 474 - 483
[7] Benralizumab in eosinophilic granulomatosis with polyangiitis complicated by Staphylococcus aureus sepsis
Kolios, Antonios G. A.
Lutterotti, Andreas
Kulcsar, Zsolt
Renner, Tobias
Rudiger, Alain
Nilsson, Jakob
[J]. CLINICAL IMMUNOLOGY, 2021, 222
[8] Decrease in MPO-ANCA after administration of benralizumab in eosinophilic granulomatosis with polyangiitis
Takenaka, Kenchi
Minami, Tomoko
Yoshihashi, Yoko
Hirata, Shinya
Kimura, Yoshitaka
Kono, Hajime
[J]. ALLERGOLOGY INTERNATIONAL, 2019, 68 (04) : 539 - 540
[9] Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
Wechsler, M. E.
Akuthota, P.
Jayne, D.
Khoury, P.
Klion, A.
Langford, C. A.
Merkel, P. A.
Moosig, F.
Specks, U.
Cid, M. C.
Luqmani, R.
Brown, J.
Mallett, S.
Philipson, R.
Yancey, S. W.
Steinfeld, J.
Weller, P. F.
Gleich, G. J.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (20) : 1921 - 1932

← 1 →